Literature DB >> 8898949

Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H.

S Kühn1, P F Zipfel.   

Abstract

The human factor H-like protein 1 (FHL-1) is composed of seven repetitive elements (short consensus repeats; SCR) that are identical in sequence to the seven N-terminal SCR of complement factor H. We show that the FHL-1 protein has decay acceleration activity in that it can dissociate C3/C5-convertases bound to the surface of sheep red blood cells. The same activity was also determined for factor H. However, compared to FHL-1, factor H was more efficient in decay acceleration, as about 100-fold less protein was required for a 50% inhibition of activity. The domain required for decay accelerating activity of FHL-1 and factor H was mapped by the use of recombinant fragments. FHL-1 and a series of truncated forms of the protein were expressed in the baculovirus system. Recombinant FHL-1 and all mutants which include SCR 1-4 were functionally active. These four N-terminal SCR are essential and sufficient for activity, as deletion mutants which lack SCR 1 or SCR 4 showed no activity. These results demonstrate that FHL-1 and factor H have identical and overlapping regulatory functions in the complement system and that the domain required for this activity is located in the overlapping region of both proteins within the N-terminal four SCR.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8898949     DOI: 10.1002/eji.1830261017

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  53 in total

1.  Role of Gonococcal Neisserial Surface Protein A (NspA) in Serum Resistance and Comparison of Its Factor H Binding Properties with Those of Its Meningococcal Counterpart.

Authors:  Lisa A Lewis; Peter A Rice; Sanjay Ram
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

Review 2.  Complement control protein factor H: the good, the bad, and the inadequate.

Authors:  Viviana P Ferreira; Michael K Pangburn; Claudio Cortés
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

Review 3.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

4.  The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein.

Authors:  M Oppermann; T Manuelian; M Józsi; E Brandt; T S Jokiranta; S Heinen; S Meri; C Skerka; O Götze; P F Zipfel
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

5.  Potentiation of complement regulator factor H protects human endothelial cells from complement attack in aHUS sera.

Authors:  Richard B Pouw; Mieke C Brouwer; Marlon de Gast; Anna E van Beek; Lambertus P van den Heuvel; Christoph Q Schmidt; Arie van der Ende; Pilar Sánchez-Corral; Taco W Kuijpers; Diana Wouters
Journal:  Blood Adv       Date:  2019-02-26

6.  Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin.

Authors:  Jutamas Shaughnessy; Lisa A Lewis; Hanna Jarva; Sanjay Ram
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

7.  Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk.

Authors:  Meike Heurich; Ruben Martínez-Barricarte; Nigel J Francis; Dawn L Roberts; Santiago Rodríguez de Córdoba; B Paul Morgan; Claire L Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

8.  M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H.

Authors:  T K Blackmore; V A Fischetti; T A Sadlon; H M Ward; D L Gordon
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

9.  The C-terminus of factor H: monoclonal antibodies inhibit heparin binding and identify epitopes common to factor H and factor H-related proteins.

Authors:  W M Prodinger; J Hellwage; M Spruth; M P Dierich; P F Zipfel
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

10.  The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15.

Authors:  Thomas G Duthy; Rebecca J Ormsby; Eleni Giannakis; A David Ogunniyi; Uwe H Stroeher; James C Paton; David L Gordon
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.